Zydus Lifesciences said its U.S.-based biopharmaceutical arm, Sentynl Therapeutics Inc, announced that the U.S. Food and Drug Administration (FDA) has approved ZYCUBO (copper histidinate) for the ...

While the VIX index ended last week unch’d at 14.5%, there were notable changes underneath the index surface. Read more here.

PFC will issue NCDs of 15-year tenor, and offer a coupon rate of 7.3% payable on an annual basis. The base size of the issue ...

As a handful of Ohio State Buckeyes began to make decisions about heading to the NFL draft, or returning for a final season ...

GPIX’s dynamic covered call overwrite boosts S&P 500 upside vs JEPI, XYLD, SPYI - plus capture ratios to assess risk/returns.

After having a successful IPO less than a year ago, this biotech innovator had notable insider transactions to close out 2025.

The early-stage results have been described as outstanding. The post Early success in battling Crohn's Disease has sent this ...

Tehran said on Monday it was keeping communication channels with Washington open as U. President Donald Trump considered how ...

Kentucky point guard Jaland Lowe will undergo season-ending shoulder surgery, Wildcats coach Mark Pope announced Monday on ...

Learn how the stock replacement strategy lets investors use call options to match stock gains with less capital, offering ...

Through four ACC games, Virginia Tech men's basketball has split its conference slate, bookending consecutive losses to Wake ...

Keithen Drury has positions in Alphabet. The Motley Fool has positions in and recommends Alphabet, International Business ...